Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut Rosell, now operating as Lallemand Health Solutions, is a pioneer in the research and production of probiotics for human health. Founded in 1934 in Montreal, the company was one of the first to develop industrial-scale fermentation for beneficial bacteria. Following its acquisition by Lallemand in 1998, it has expanded into a global leader, providing vertically integrated services from strain selection to finished product manufacturing. The company's portfolio features well-documented probiotic strains, including the Rosell® and Harmonium® lines, which are supported by extensive clinical documentation. Their products target diverse therapeutic areas such as gastrointestinal health, natural defenses, and the gut-brain axis. Institut Rosell remains a key innovation hub for microbiome-based solutions, serving the dietary supplement and functional food industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut Rosell.